Mode
Text Size
Log in / Sign up

End-stage kidney disease

Part of Chronic Kidney Disease

6 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for End-stage kidney disease

9 trials tracked for End-stage kidney disease: 2 in phase 3 or 4.

9Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 2 Phase 2 1 Phase 1 1 Other / NA 5
  1. Phase 3 Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes Completed
  2. Phase 3 Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1) Completed
  3. Phase 2 Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007) Completed
  4. Phase 1 A Study of MK-2060 in Participants With Chronic and/or End-Stage Kidney Disease (MK-2060-011) Completed
  5. N/A Electronic Patient-Reported Outcomes in Clinical Kidney Practice (ePRO Kidney) Completed
  6. N/A Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD Completed
Show 3 more trials
  1. N/A Ellipsys Vascular Access System Post Market Surveillance (PS) Study Completed
  2. N/A Phenotyping Seroconversion Following Vaccination Against COVID-19 in Patients on Haemodialysis Study Completed
  3. N/A Continuous Glucose Monitoring in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes Completed

Showing the 9 most-cited and recently-updated of 9 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Chronic Kidney Disease

Related studies from across the Chronic Kidney Disease family.

Ambulatory hypertension in pediatric chronic kidney disease patients increases risk of left ventricular hypertrophy
Pediatrics Meta-analysis
Ambulatory hypertension in pediatric chronic kidney disease patients increases risk of left ventricular hypertrophy High Blood Pressure Linked to Heart Changes in Children
This meta-analysis of 51 studies involving 6509 children with chronic kidney disease found that ambulatory hypertension is associated with i…
New data shows a strong link between high blood pressure and heart muscle thickening in children with chronic kidney disease.
Roxadustat increases odds of vascular access thrombosis and all-cause mortality in patients with chronic kidney disease
Drug Pipeline Meta-analysis
Roxadustat increases odds of vascular access thrombosis and all-cause mortality in patients with chronic kidney disease Roxadustat Linked to Higher Risk of Blood Clots in Kidney Patients
This systematic review and meta-analysis of 11,418 adults with chronic kidney disease found that roxadustat is associated with higher odds o…
A review of over 11,000 patients suggests roxadustat may increase the risk of blood clots and death for those with chronic kidney disease.
Cystatin C shows good diagnostic performance with an AUC of 0.88 for early detection of SA-AKI
Nephrology Meta-analysis
Cystatin C shows good diagnostic performance with an AUC of 0.88 for early detection of SA-AKI Cystatin C shows promise for early detection of kidney injury
This meta-analysis of 17 studies evaluates the diagnostic performance of Cystatin C for detecting acute kidney injury in patients with sepsi…
A new look at 17 studies suggests that Cystatin C could help doctors identify kidney damage in sepsis patients much earlier than current met…
Semaglutide reduces risk of kidney decline or death in type 2 diabetes and CKD
Diabetes & Endocrinology RCT
Semaglutide reduces risk of kidney decline or death in type 2 diabetes and CKD Semaglutide lowers kidney and heart risks in type 2 diabetes patients
This randomized controlled trial enrolled 3,533 participants with type 2 diabetes and chronic kidney disease. Once-weekly subcutaneous semag…
A large trial shows once-weekly semaglutide reduces kidney failure and death risks in people with type 2 diabetes and chronic kidney disease…
Gut microbiota dysbiosis and microbial metabolites impair renal function in sepsis-associated acute kidney injury
Nephrology Sys. Review
Gut microbiota dysbiosis and microbial metabolites impair renal function in sepsis-associated acute kidney injury Sepsis may damage kidneys by letting gut bacteria toxins leak into the blood
This narrative review examines the role of gut microbiota dysbiosis in sepsis-associated acute kidney injury and acute kidney injury. The au…
A review suggests that sepsis changes gut bacteria, causing harmful toxins to leak and hurt kidneys in humans and animals.
Jinlida Granule reduces serum creatinine and HbA1c in diabetic kidney disease patients across a meta-analysis
Drug Pipeline Meta-analysis
Jinlida Granule reduces serum creatinine and HbA1c in diabetic kidney disease patients across a meta-analysis Jinlida Granule lowers key kidney markers in diabetic kidney disease patients
This systematic review and meta-analysis evaluated Jinlida Granule for diabetic kidney disease in 1,341 patients. The pooled analysis showed…
A large review of 1,341 patients found Jinlida Granule significantly lowered kidney stress markers and blood sugar levels compared to standa…
Steroid avoidance may reduce death and diabetes after kidney transplant but raises rejection risk
Cardiology Sys. Review
Steroid avoidance may reduce death and diabetes after kidney transplant but raises rejection risk Steroid avoidance after kidney transplant may reduce death and diabetes
This systematic review of 53 studies (8317 participants) found that steroid avoidance may reduce all-cause death at 1-5 years and post-trans…
Skipping steroids after a kidney transplant might lower the risk of death and diabetes, but could raise the chance of rejection.
ILC dysregulation and gut microbiota dysbiosis may drive kidney disease via the microbiota-gut-kidney axis
Nephrology Sys. Review
ILC dysregulation and gut microbiota dysbiosis may drive kidney disease via the microbiota-gut-kidney axis Gut bacteria imbalance may drive kidney disease inflammation
This narrative review explores the proposed role of ILC dysregulation and gut-derived metabolic signals in chronic kidney disease. The autho…
A new review suggests that imbalances in gut bacteria and immune cells might explain why kidney disease causes inflammation. This points to …
Fluoroless ultrasound-guided techniques lower complications in percutaneous nephrolithotomy with equivalent stone-free rates
Urology Meta-analysis
Fluoroless ultrasound-guided techniques lower complications in percutaneous nephrolithotomy with equivalent stone-free rates Fluoroless ultrasound guidance reduces complications during kidney stone surgery
This systematic review and meta-analysis of randomized studies evaluated fluoroless ultrasound-guided versus fluoroscopy-guided techniques f…
A meta-analysis of randomized trials shows that using ultrasound instead of X-ray guidance lowers overall complications for kidney stone rem…
ECIRS triples stone-free odds versus PCNL in large kidney stones, meta-analysis finds
Urology Meta-analysis
ECIRS triples stone-free odds versus PCNL in large kidney stones, meta-analysis finds New surgery clears kidney stones better than the standard method without more risk
This systematic review and meta-analysis of 1988 patients with high stone burden found that endoscopic combined intrarenal surgery (ECIRS) s…
A new analysis shows a specific surgery clears kidney stones faster and with fewer complications than the standard approach for tough cases.
Chronic kidney disease linked to shorter leukocyte telomere length in meta-analysis
Nephrology Meta-analysis
Chronic kidney disease linked to shorter leukocyte telomere length in meta-analysis Chronic kidney disease patients have shorter telomeres than healthy controls
This meta-analysis of case-control and pooled data found that chronic kidney disease is associated with shorter leukocyte telomere length. T…
People with chronic kidney disease show shorter telomeres than healthy people, a sign of faster biological aging linked to their disease.
Education and behavior interventions reduce burden for CKD caregivers in a systematic review
Nephrology Meta-analysis
Education and behavior interventions reduce burden for CKD caregivers in a systematic review Brief programs may ease burden for CKD family caregivers
This systematic review and meta-analysis examined informal caregivers of people with chronic kidney disease. Twelve studies identified a sig…
A review of thirteen studies suggests brief education and behavior programs may reduce burden for family caregivers of people with chronic k…

Questions about End-stage kidney disease

Can mineralocorticoid receptor antagonists reduce heart events in dialysis patients?

Yes, MRAs reduce nonfatal heart events in dialysis patients but raise risks of high potassium and breast tenderness; talk to your doctor about the balance.

Full answer →